Medicare News and Research

RSS
Liberator Medical Holdings reports net revenues of $9.65M for second fiscal quarter 2010

Liberator Medical Holdings reports net revenues of $9.65M for second fiscal quarter 2010

First Edition: May 12, 2010

First Edition: May 12, 2010

R.I. overhauls Medicaid payments for elderly, disabled; Medicaid delays reported in Kansas

R.I. overhauls Medicaid payments for elderly, disabled; Medicaid delays reported in Kansas

Sebelius heralds early successes of health law

Sebelius heralds early successes of health law

CMS will keep a close eye on 'innovation' funding

CMS will keep a close eye on 'innovation' funding

Nurses lobby for more protections; Med school enrollment misses target

Nurses lobby for more protections; Med school enrollment misses target

NeuroMetrix first-quarter total revenues decrease to $3.7 million

NeuroMetrix first-quarter total revenues decrease to $3.7 million

Reinsurance program will help companies provide health insurance for early retirees

Reinsurance program will help companies provide health insurance for early retirees

Cancer costs double in 20 years but are still in line with overall health spending, study finds

Cancer costs double in 20 years but are still in line with overall health spending, study finds

New law could help hospice patients continue aggressive medical treatments

New law could help hospice patients continue aggressive medical treatments

Overhaul will bring changes, improve quality for Medicare Advantage plans

Overhaul will bring changes, improve quality for Medicare Advantage plans

Consumers, officials work to sort out new health law

Consumers, officials work to sort out new health law

Companies get help to insure early retirees

Companies get help to insure early retirees

Companies await health IT windfall

Companies await health IT windfall

Watson Pharmaceuticals first-quarter net revenue up 28% to $856.5M

Watson Pharmaceuticals first-quarter net revenue up 28% to $856.5M

First Edition: May 10, 2010

First Edition: May 10, 2010

Radnet first-quarter revenue down, net loss up

Radnet first-quarter revenue down, net loss up

NIAMS, NINDS announce 5-year, $7.5M natural history study of Duchenne muscular dystrophy

NIAMS, NINDS announce 5-year, $7.5M natural history study of Duchenne muscular dystrophy

Zilver PTX Drug-Eluting Peripheral Stent safe and effective for treating SFA lesions

Zilver PTX Drug-Eluting Peripheral Stent safe and effective for treating SFA lesions

Costs and quality of cancer care in the U.S.

Costs and quality of cancer care in the U.S.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.